2020
DOI: 10.1021/acs.jnatprod.0c01209
|View full text |Cite
|
Sign up to set email alerts
|

Isolation, Structure Determination, and Total Synthesis of Hoshinoamide C, an Antiparasitic Lipopeptide from the Marine Cyanobacterium Caldora penicillata

Abstract: Hoshinoamide C (1), an antiparasitic lipopeptide, was isolated from the marine cyanobacterium Caldora penicillata. Its planar structure was elucidated by spectral analyses, mainly 2D NMR, and the absolute configurations of the α-amino acid moieties were determined by degradation reactions followed by chiral-phase HPLC analyses. To clarify the absolute configuration of an unusual amino acid moiety, we synthesized two possible diastereomers of hoshinoamide C and determined its absolute configuration based on a c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 16 publications
0
8
0
Order By: Relevance
“…Hoshinoamide C did not exhibit any toxicity against HL-60 or HeLa cells at 10 μM, but inhibited the growth of the parasites responsible for African sleeping sickness (IC 50 2.9 μM) and malaria (IC 50 0.96 μM). 110 Motobamide 224 , a new cyclic decapeptide containing a C -prenylated cyclotryptophan residue, was isolated from a marine Leptolyngbya sp. ; this MNP inhibited the growth of bloodstream forms of Trypanosoma brucei rhodesiense (IC 50 2.3 μM) and showed no cytotoxicity against three human cell lines.…”
Section: Marine Microorganisms and Phytoplanktonmentioning
confidence: 99%
See 1 more Smart Citation
“…Hoshinoamide C did not exhibit any toxicity against HL-60 or HeLa cells at 10 μM, but inhibited the growth of the parasites responsible for African sleeping sickness (IC 50 2.9 μM) and malaria (IC 50 0.96 μM). 110 Motobamide 224 , a new cyclic decapeptide containing a C -prenylated cyclotryptophan residue, was isolated from a marine Leptolyngbya sp. ; this MNP inhibited the growth of bloodstream forms of Trypanosoma brucei rhodesiense (IC 50 2.3 μM) and showed no cytotoxicity against three human cell lines.…”
Section: Marine Microorganisms and Phytoplanktonmentioning
confidence: 99%
“…The first total syntheses of 14 cyanobacterial metabolites were accomplished in 2021, laingolide A 240 , 118 kinenzoline 221 , 108 hoshinoamides A 119 and C 223 , 110 iheyamide A and iheyanone 227 , 113 bromoiesol sulfate A 236 and bromoiesol A 238 , 117 gatorbulin-1 225 , 112 27-deoxylyngbyabellin A, 120 laucysteinamide A, 121 oscillatoxins E and F, 122 and (−)-majusculoic acid. 123 The asymmetric synthesis of four diastereomers of laingolide A 240 led to the unambiguous assignment of the stereochemistry for this MNP.…”
Section: Marine Microorganisms and Phytoplanktonmentioning
confidence: 99%
“…In recent years, Iwasaki and co-workers have reported three novel linear lipopeptide natural products, hoshinoamides A, B [ 11 ] and C [ 12 ], from a microbial metabolite of marine cyanobacterium Caldora penicillata ( Figure 1 ). Hoshinoamides A and B showed potent activities against chloroquine-sensitive Plasmodium falciparum 3D7 with IC 50 values of 0.52 and 1.0 μM, respectively.…”
Section: Introductionmentioning
confidence: 99%
“…Hoshinoamide C inhibited the growth of the malaria parasites (IC 50 = 0.96 μM) and African sleeping sickness (IC 50 = 2.9 μM). Hoshinoamide C was firstly synthesized from Boc-protected amino acids in liquid phase [12]. Both hoshinoamides A and B are highly methylated polypeptides containing three N-methyl amino acids: N-Me-ʟ-Leu 7 , N-Me-ᴅ-Val 5 and N-Me-ᴅ/ʟ-Phe 2 .…”
Section: Introductionmentioning
confidence: 99%
“…In recent years, Iwasaki and co-workers reported three novel linear lipopeptides natural products, Hoshinoamides A, B [11] and C [12] , from a microbial metabolite of marine cyanobacterium Caldora penicillata (Figure 1). Hoshinoamides A and B showed potent activities against chloroquine-sensitive Plasmodium falciparum 3D7 with IC50 values of 0.52 and 1.0 μM, respectively.…”
Section: Introductionmentioning
confidence: 99%